Logo image of NEXT.OL

NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Fundamental Analysis

OSL:NEXT - NO0010629108 - Common Stock

3.48 NOK
0 (0%)
Last: 9/9/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, NEXT scores 2 out of 10 in our fundamental rating. NEXT was compared to 50 industry peers in the Electronic Equipment, Instruments & Components industry. NEXT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NEXT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NEXT had negative earnings in the past year.
In the past year NEXT has reported a negative cash flow from operations.
NEXT had negative earnings in each of the past 5 years.
In the past 5 years NEXT always reported negative operating cash flow.
NEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFNEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

NEXT's Return On Assets of -68.81% is on the low side compared to the rest of the industry. NEXT is outperformed by 90.00% of its industry peers.
NEXT has a Return On Equity of -90.13%. This is amonst the worse of the industry: NEXT underperforms 88.00% of its industry peers.
Industry RankSector Rank
ROA -68.81%
ROE -90.13%
ROIC N/A
ROA(3y)-41%
ROA(5y)-47.51%
ROE(3y)-52%
ROE(5y)-61.09%
ROIC(3y)N/A
ROIC(5y)N/A
NEXT.OL Yearly ROA, ROE, ROICNEXT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

Looking at the Gross Margin, with a value of 47.55%, NEXT is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
NEXT's Gross Margin has improved in the last couple of years.
NEXT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.73%
GM growth 5Y17.56%
NEXT.OL Yearly Profit, Operating, Gross MarginsNEXT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

6

2. Health

2.1 Basic Checks

NEXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
NEXT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NEXT has more shares outstanding
NEXT has a worse debt/assets ratio than last year.
NEXT.OL Yearly Shares OutstandingNEXT.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly Total Debt VS Total AssetsNEXT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

NEXT has an Altman-Z score of 8.69. This indicates that NEXT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.69, NEXT belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that NEXT is not too dependend on debt financing.
NEXT has a better Debt to Equity ratio (0.02) than 92.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 8.69
ROIC/WACCN/A
WACC8.48%
NEXT.OL Yearly LT Debt VS Equity VS FCFNEXT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

2.3 Liquidity

A Current Ratio of 4.21 indicates that NEXT has no problem at all paying its short term obligations.
NEXT has a better Current ratio (4.21) than 92.00% of its industry peers.
A Quick Ratio of 3.27 indicates that NEXT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.27, NEXT belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.21
Quick Ratio 3.27
NEXT.OL Yearly Current Assets VS Current LiabilitesNEXT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

NEXT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.26%.
The Revenue for NEXT has decreased by -12.10% in the past year. This is quite bad
The Revenue has been decreasing by -3.25% on average over the past years.
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y12.14%
Revenue growth 5Y-3.25%
Sales Q2Q%-111.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEXT.OL Yearly Revenue VS EstimatesNEXT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly EPS VS EstimatesNEXT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NEXT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEXT.OL Price Earnings VS Forward Price EarningsNEXT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEXT.OL Per share dataNEXT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NEXT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXT BIOMETRICS GROUP AS

OSL:NEXT (9/9/2025, 7:00:00 PM)

3.48

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-05 2025-11-05
Inst Owners11.18%
Inst Owner ChangeN/A
Ins Owners7.42%
Ins Owner ChangeN/A
Market Cap400.72M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.87
P/FCF N/A
P/OCF N/A
P/B 5.9
P/tB 6.03
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS0.39
BVpS0.59
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.81%
ROE -90.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.55%
FCFM N/A
ROA(3y)-41%
ROA(5y)-47.51%
ROE(3y)-52%
ROE(5y)-61.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.73%
GM growth 5Y17.56%
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.44%
Cap/Sales 3.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.21
Quick Ratio 3.27
Altman-Z 8.69
F-Score2
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)4.07%
Cap/Depr(5y)3.14%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y12.14%
Revenue growth 5Y-3.25%
Sales Q2Q%-111.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-74.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.36%
OCF growth 3YN/A
OCF growth 5YN/A